Aarti Pharmalabs Limited

BSE: AARTIPHARM543748ISIN INE0LRU01027

Healthcare
Pharmaceuticals
BSE 1000

Share price

₹926.75+7.15 (+0.78%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,001.55
52W low: ₹583.85
Off 52W high: -7.47%
1M return: -2.14%
3M return: +35.22%
6M return: +17.53%
1Y return: +9.75%
20D avg volume: 38,230
50 DMA: ₹874.12
200 DMA: ₹750.34

Key ratios Consolidated

Market cap: ₹8,404 Cr
Current price: ₹926.75
52W high / low: ₹1,001.55 / ₹583.85
Face value: ₹5.00
P/E: 32.74
P/B: 3.73
EPS (TTM): ₹28.31
Book value / share: ₹248.65
ROE: —
ROCE: 10.70%
Operating margin: —
Net margin: —
Debt / equity: 0.32
Net debt: ₹677.10 Cr
Interest cover: 5.80
Dividend yield: 0.38%
Dividend / share (TTM): ₹3.50
Payout: 12.36%
Cash conversion cycle: 178.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	610.45	535.80	582.64	432.27	418.33	386.19	563.78	537.78	458.03	555.49	505.77	448.69
	0.47	0.45	8.05	0.37	0.05	1.60	-1.61	5.03	4.48	2.22	2.04	1.39
	610.92	536.25	590.70	431.90	418.39	387.79	562.17	542.81	462.51	557.71	507.80	450.08
	520.77	442.60	514.53	371.16	379.05	320.54	447.55	442.18	390.74	484.03	412.05	376.26
	334.88	251.87	225.76	209.42	203.47	191.42	185.45	261.19	220.58	219.81	201.52	214.96
	18.49	27.42	8.73	2.14	23.26	21.82	16.27	7.87	98.10	86.94	59.91	38.46
	54.55	50.33	45.05	43.38	43.41	41.26	43.37	41.63	37.73	39.23	37.40	36.16
	14.95	12.88	16.86	12.58	10.67	6.79	6.58	9.97	5.51	4.83	4.68	4.48
	30.53	30.03	28.16	28.62	24.77	22.79	22.82	23.04	20.88	20.17	19.12	18.77
	121.81	112.77	141.44	113.93	90.43	80.29	96.03	92.23	91.05	81.56	97.73	72.43
	90.15	93.66	76.17	60.74	39.34	67.25	114.62	100.63	71.77	73.68	95.75	73.82
	-2.04	0.00	0.00	-2.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	88.11	93.66	76.17	57.95	39.34	67.25	114.62	100.63	71.77	73.68	95.75	73.82
	23.52	24.92	20.55	14.91	10.77	15.95	26.28	26.64	17.14	18.22	30.50	21.06
	71.47	76.14	61.12	47.96	27.92	49.50	88.34	73.99	54.62	55.45	65.25	52.76
	7.88	8.40	6.74	5.29	3.08	5.46	9.75	8.16	6.03	6.12	7.20	5.82
Key metrics
	133.59	136.57	121.19	99.15	74.78	96.83	144.02	133.64	98.16	98.68	119.55	97.07
	21.90%	25.50%	20.80%	22.90%	17.90%	25.10%	25.50%	24.90%	21.40%	17.80%	23.60%	21.60%
	11.70%	14.20%	10.50%	11.10%	6.70%	12.80%	15.70%	13.80%	11.90%	10.00%	12.90%	11.80%
	3.90%	—	3.70%	—	2.00%	—	5.40%	—	—	—	—	—
	45.90%	38.70%	3.30%	-19.60%	-8.70%	-30.50%	11.50%	19.90%	—	—	—	—
	156.00%	53.80%	-30.80%	-35.20%	-48.90%	-10.70%	35.40%	40.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	2,161	1,819	2,115	1,853	1,945
	9.34	9.75	10.12	4.89	2.32
	2,170	1,829	2,125	1,858	1,948
	1,849	1,601	1,764	1,557	1,687
	1,022	830.06	887.02	858.45	1,014
	56.78	55.95	176.63	182.22	280.82
	193.31	173.09	161.96	138.41	129.69
	57.27	46.90	26.90	17.21	21.05
	117.34	104.34	86.90	73.23	62.54
	489.95	442.31	360.87	307.44	303.74
	320.72	227.72	360.69	300.49	260.77
	-4.83	-2.79	0.00	0.00	0.00
	315.89	224.92	360.69	300.49	260.77
	83.90	58.21	88.28	83.59	67.28
	256.69	174.71	272.40	216.90	193.49
	28.31	19.27	30.06	23.93	21.35
Key metrics
	490.50	376.16	474.49	390.93	344.36
	22.70%	20.70%	22.40%	21.10%	17.70%
	11.88%	9.60%	12.90%	11.70%	9.90%
	—	10.70%	17.20%	—	—
	13.38%	-14.00%	14.20%	-4.80%	—
	7.07%	-35.90%	25.60%	12.10%	—
	—	-147.44	-70.48	—	—
	—	1.50	1.22	—	—
	—	0.32	0.20	—	—
	—	677.10	389.63	—	—
	—	178.4	152.8	—	—
Balance sheet
	—	3,482	2,906	—	—
	—	1,397	1,322	—	—
	—	8.53	6.73	—	—
	—	583.32	575.40	—	—
	—	640.31	587.58	—	—
	—	—	96.82	—	—
	—	1,336	1,104	—	—
	—	334.54	277.83	—	—
	—	937.57	657.05	—	—
	—	685.63	396.36	—	—
	—	499.82	292.80	—	—
	—	185.81	103.56	—	—
	—	2,125	1,990	—	—
Cash flow
	—	261.93	331.56	—	—
	—	-430.72	-413.90	—	—
	—	170.58	65.44	—	—
	—	409.37	402.04	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	612.59	534.59	579.70	425.25	417.29	375.31	529.62	470.95	377.29	393.49	414.82	373.03
	0.47	2.93	10.53	0.37	3.15	1.60	-2.50	11.94	2.95	2.11	5.69	0.20
	613.05	537.52	590.23	424.88	420.44	376.91	527.12	482.88	380.24	395.60	420.50	373.23
	521.74	441.30	507.65	363.51	378.74	309.73	413.62	386.70	316.81	332.37	329.22	305.79
	331.91	254.84	227.38	209.85	204.45	192.85	173.29	242.91	196.38	191.41	179.69	191.11
	21.43	24.45	7.07	1.86	20.41	19.85	3.34	2.44	20.00	1.65	—	—
	53.94	49.77	43.73	42.62	43.12	41.01	41.38	39.02	35.47	37.01	34.67	34.29
	14.95	12.87	16.86	12.58	10.66	6.79	6.29	9.70	5.39	4.25	4.42	4.10
	30.53	30.03	28.16	28.62	24.77	22.76	20.83	21.04	18.89	18.29	17.32	16.94
	121.51	112.06	138.94	108.25	90.19	79.41	85.02	80.75	77.23	69.67	85.75	64.68
	91.31	96.22	82.59	61.38	41.70	67.17	113.50	96.18	63.43	63.23	91.28	67.44
	-2.04	0.00	0.00	-2.79	0.00	0.00	0.00	—	—	—	—	—
	89.27	96.22	82.59	58.58	41.70	67.17	113.50	96.18	63.43	63.23	91.28	67.44
	23.52	24.92	20.55	14.74	10.77	15.95	24.66	22.66	15.60	16.08	28.26	19.25
	65.75	71.31	62.03	43.84	30.93	51.22	88.85	73.52	47.84	47.14	63.02	48.19
	7.25	7.87	6.84	4.84	3.41	5.65	9.80	8.11	5.28	5.20	6.95	5.32
Key metrics
	134.75	139.12	127.61	99.78	77.13	96.72	140.62	126.92	87.71	85.77	113.02	88.48
	22.00%	26.00%	22.00%	23.50%	18.50%	25.80%	26.60%	26.90%	23.20%	21.80%	27.20%	23.70%
	10.70%	13.30%	10.70%	10.30%	7.40%	13.60%	16.80%	15.60%	12.70%	12.00%	15.20%	12.90%
	4.20%	—	4.10%	—	2.30%	—	5.70%	—	—	—	—	—
	46.80%	42.40%	9.50%	-9.70%	10.60%	-4.60%	27.70%	26.20%	—	—	—	—
	112.60%	39.20%	-30.20%	-40.40%	-35.30%	8.70%	41.00%	52.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	2,152	1,798	1,771	1,502	1,511
	14.30	15.32	14.49	11.01	1.28
	2,166	1,813	1,786	1,513	1,513
	1,834	1,576	1,450	1,239	1,279
	1,024	834.53	803.98	761.57	899.45
	54.81	49.19	27.43	13.76	9.70
	190.06	170.48	152.88	130.33	122.16
	57.26	46.90	25.63	16.63	20.48
	117.34	104.30	79.06	66.01	55.77
	480.76	433.02	312.66	273.67	262.83
	331.50	237.03	336.34	274.52	233.36
	-4.83	-2.79	0.00	—	—
	326.66	234.24	336.34	274.52	233.36
	83.73	58.04	78.99	73.87	61.63
	242.93	176.20	257.35	200.65	171.73
	26.80	19.44	28.39	22.14	18.95
Key metrics
	501.26	385.44	441.03	357.16	309.61
	23.29%	21.40%	24.90%	23.80%	20.50%
	11.29%	9.80%	14.50%	13.40%	11.40%
	—	11.70%	17.20%	—	—
	20.02%	1.50%	17.90%	-0.60%	—
	-0.65%	-31.50%	28.30%	16.80%	—
	—	-153.24	-51.47	—	—
	—	1.45	1.32	—	—
	—	0.35	0.21	—	—
	—	680.09	392.02	—	—
	—	182.4	174.7	—	—
Balance sheet
	—	3,328	2,724	—	—
	—	1,393	1,213	—	—
	—	5.54	2.84	—	—
	—	586.55	552.59	—	—
	—	636.21	544.22	—	—
	—	153.61	87.52	—	—
	—	1,336	1,029	—	—
	—	324.30	248.97	—	—
	—	925.88	622.33	—	—
	—	685.63	394.86	—	—
	—	499.82	291.30	—	—
	—	185.81	103.56	—	—
	—	1,982	1,844	—	—
Cash flow
	—	256.13	340.01	—	—
	—	-424.02	-419.80	—	—
	—	170.58	78.63	—	—
	—	409.37	391.48	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +5.95%
Sales CAGR 5Y: —
Profit CAGR 3Y: +0.86%
Profit CAGR 5Y: —
Sales YoY (TTM): +20.02%
Profit YoY (TTM): -0.65%

Consolidated

Sales CAGR 3Y: -2.20%
Sales CAGR 5Y: —
Profit CAGR 3Y: -3.35%
Profit CAGR 5Y: —
Sales YoY (TTM): +13.38%
Profit YoY (TTM): +7.07%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 39.67%

Quarter	September 2026	June 2026
Promoter %	39.67%	42.87%

Holder	Type	Holding	Previous	Change
Life Insurance Corporation Of India	Public	4.72%	5.27%	-0.55%
Rashesh Chandrakant Gogri	Promoter Group	4.23%	4.23%	0.00%
Jaya Chandrakant Gogri	Promoter Group	3.53%	3.53%	0.00%
Anushakti Enterprise Private Limited	Promoter Group	3.30%	3.30%	0.00%
LABDHI BUSINESS TRUST(Saswat Trusteeship Private Limited)	Promoter Group	3.13%	3.13%	0.00%
Hetal Gogri Gala	Promoter Group	3.11%	3.11%	0.00%
Mirik Rajendra Gogri	Promoter Group	3.07%	3.07%	0.00%
Renil Rajendra Gogri	Promoter Group	2.80%	2.80%	0.00%
Sarla Shantilal Shah	Promoter	2.69%	2.69%	0.00%
MANOMAYA BUSINESS TRUST(Alabhya Trusteeship Private Limited)	Promoter Group	1.44%	1.44%	0.00%
Nehal Garewal	Promoter Group	1.24%	1.24%	0.00%
Rajendra Vallabhaji Gogri	Promoter	1.14%	1.57%	-0.43%
Nishant Pradip Shah	Public	1.10%	1.10%	0.00%
Heena Family Private Trust(Barclays Wealth Trustees India Private Limited)	Promoter Group	0.92%	0.92%	0.00%
Bhavna Family Private Trust(Barclays Wealth Trustees India Pvt Ltd)	Promoter	0.89%	0.89%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Aarti Pharmalabs Limited	8,404	926.75	32.74	10.70%	+13.38% TTM	+7.07% TTM	+9.75%

Filings & corporate actions

Recent announcements

Q2 FY 27 Earnings Call Transcript4 Nov 2026 · Company Update / Earnings Call Transcript
Newspaper Publication of Financial Results30 Oct 2026 · Company Update / Newspaper Publication
Audio Recording of Conference Call for Investor and Analysts29 Oct 2026 · Company Update / Analyst / Investor Meet
Q2 FY 2027 Investor Presentation29 Oct 2026 · Company Update / Investor Presentation
Please find enclosed28 Oct 2026 · Company Update / General
Please find enclosed28 Oct 2026 · Company Update / Change in Management
Please find enclosed28 Oct 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Please find enclosed28 Oct 2026 · Result / Financial Results
Please find enclosed28 Oct 2026 · Board Meeting / Outcome of Board Meeting
Please find enclosed28 Oct 2026 · Company Update / General
Please find enclosed28 Oct 2026 · Company Update / General
This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Thursday, October 28, 2026, at 3:30 p.m. (IST) to discuss the Company''s Q2-FY27 ....22 Oct 2026 · Company Update / Analyst / Investor Meet
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Unaudited Standalone And Consolidated ....9 Oct 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026.9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed30 Sep 2026 · Company Update / General
Please find enclosed30 Sep 2026 · Company Update / General
Closure of Trading Window28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed23 Sep 2026 · Company Update / General
Scrutinizers Report and Voting Result of 7th Annual General Meeting23 Sep 2026 · AGM/EGM / AGM
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gloire Trusteeship Services Pvt Ltd & Others23 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Investor Presentation made at the 7th Annual General Meeting22 Sep 2026 · Company Update / Investor Presentation
Proceedings of the 7th Annual General Meeting22 Sep 2026 · AGM/EGM / AGM
Please find enclosed2 Sep 2026 · Company Update / General
Please find enclosed31 Aug 2026 · Company Update / Change in Management
Please find enclosed30 Aug 2026 · Company Update / Newspaper Publication
Please find enclosed BRSR for FY 2025-2629 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed29 Aug 2026 · AGM/EGM / AGM
Please find enclosed, Annual Report for FY 2025-2629 Aug 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed18 Aug 2026 · Company Update / Newspaper Publication
Disclosure as enclosed17 Aug 2026 · Corp. Action / Record Date
Q1 FY 27 Earnings Call Transcript17 Aug 2026 · Company Update / Earnings Call Transcript
Audio Recording of Conference Call for Investor and Analysts10 Aug 2026 · Company Update / Analyst / Investor Meet
Q1 FY 2027 Investor Presentation10 Aug 2026 · Company Update / Investor Presentation
Newspaper Publication on Financial Results9 Aug 2026 · Company Update / Newspaper Publication
As enclosed7 Aug 2026 · Company Update / Change in Directorate
Disclosure as enclosed7 Aug 2026 · Company Update / General
Disclosure as enclosed7 Aug 2026 · Company Update / Change in Directorate
Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter Ended June 30, 20267 Aug 2026 · Result / Financial Results
Outcome of Board Meeting held on August 07, 2026.7 Aug 2026 · Board Meeting / Outcome of Board Meeting
This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Monday, August 10, 2026, at 4:00 p.m. (IST) to discuss the Company''s Q1-FY27 Financial ....3 Aug 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.0000	15 Sep 2026	15 Sep 2026	—
Interim Dividend - Rs. - 1.5000	16 Feb 2026	16 Feb 2026	—
Final Dividend - Rs. - 2.5000	15 Sep 2025	15 Sep 2025	—
Interim Dividend - Rs. - 2.5000	14 Feb 2025	14 Feb 2025	—
Final Dividend - Rs. - 1.0000	31 Jul 2024	31 Jul 2024	—

Board meetings

28 Oct 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results